RDF/XML JSON-LD N3/Turtle RDF/JSON

Díaz Villamarín, Xando Author

Open Access

Novel Genetic Variants Explaining Severe Adverse Drug Events after Clinical Implementation of <i>DPYD</i> Genotype-Guided Therapy with Fluoropyrimidines: An Observational Study

  • Xando Díaz-Villamarín
  • María Martínez-Pérez
  • María Teresa Nieto-Sánchez
  • Gabriela Ruiz-Tueros
  • Emilio Fernández-Varón
  • Alicia Torres-García
  • Beatriz González Astorga
  • Isabel Blancas
  • Antonio J. Iáñez
  • José Cabeza-Barrera
  • Rocío Morón
... View more Collapse

PHARMACEUTICS - 1/7/2024

10.3390/pharmaceutics16070956

Cite count:
Open Access

Selective Digestive Decontamination: A Comprehensive Approach to Reducing Nosocomial Infections and Antimicrobial Resistance in the ICU

  • María Martínez-Pérez
  • Rosario Fernández-Fernández
  • Rocío Morón
  • María Teresa Nieto-Sánchez
  • María Eugenia Yuste
  • Xando Díaz-Villamarín
  • Emilio Fernández-Varón
  • Alberto Vázquez-Blanquiño
  • Ana Alberola-Romano
  • José Cabeza-Barrera
  • Manuel Colmenero
... View more Collapse

JOURNAL OF CLINICAL MEDICINE - 1/11/2024

10.3390/jcm13216482

Cite count:
Open Access

Economic evaluation of pharmacogenomic-guided antiplatelet treatment in Spanish patients suffering from acute coronary syndrome participating in the U-PGx PREPARE study

  • Koufaki M.I.
  • Fragoulakis V.
  • Díaz-Villamarín X.
  • Karamperis K.
  • Vozikis A.
  • Swen J.J.
  • Dávila-Fajardo C.L.
  • Vasileiou K.Z.
  • Patrinos G.P.
  • Mitropoulou C.
... View more Collapse

HUMAN GENOMICS - 7/6/2023

10.1186/s40246-023-00495-3

Cite count: 11 (Web of Science) 10 (Scopus)
  • JCR Impact Factor: 3.8 (2023)
  • CiteScore: 8.8 (2022)
  • JCR 5-year Impact Factor: 4
  • JCR Categories: GENETICS & HEREDITY

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

  • Swen J.J.
  • van der Wouden C.H.
  • Manson L.E.
  • Abdullah-Koolmees H.
  • Blagec K.
  • Blagus T.
  • Böhringer S.
  • Cambon-Thomsen A.
  • Cecchin E.
  • Cheung K.C.
  • Deneer V.H.
  • Dupui M.
  • Ingelman-Sundberg M.
  • Jonsson S.
  • Joefield-Roka C.
  • Just K.S.
  • Karlsson M.O.
  • Konta L.
  • Koopmann R.
  • Kriek M.
  • Lehr T.
  • Mitropoulou C.
  • Rial-Sebbag E.
  • Rollinson V.
  • Roncato R.
  • Samwald M.
  • Schaeffeler E.
  • Skokou M.
  • Schwab M.
  • Steinberger D.
  • Stingl J.C.
  • Tremmel R.
  • Turner R.M.
  • van Rhenen M.H.
  • Dávila Fajardo C.L.
  • Dolžan V.
  • Patrinos G.P.
  • Pirmohamed M.
  • Sunder-Plassmann G.
  • Toffoli G.
  • Guchelaar H.J.
  • Buunk A.
  • Goossens H.
  • Baas G.
  • Algera M.
  • Schuil-Vlassak E.
  • Ambagts T.
  • De Hoog-Schouten L.
  • Musaafir S.
  • Bosch R.
  • Tjong C.
  • Steeman S.
  • Van der Plas M.
  • Baldew G.
  • Den Hollander I.
  • De Waal Z.
  • Heijn A.
  • Nelemans L.
  • Kouwen-Lubbers K.
  • Van Leeuwen M.
  • Hoogenboom S.
  • Van Doremalen J.
  • Ton C.
  • Beetstra B.
  • Meijs V.
  • Dikken J.
  • Dubero D.
  • Slager M.
  • Houben T.
  • Kanis T.
  • Overmars W.
  • Nijenhuis M.
  • Steffens M.
  • Bergs I.
  • Karamperis K.
  • Siamoglou S.
  • Ivantsik O.
  • Samiou G.C.
  • Kordou Z.
  • Tsermpini E.
  • Ferentinos P.
  • Karaivazoglou A.
  • Rigas G.
  • Gerasimou H.
  • Voukelatou G.
  • Georgila E.
  • Tsermpini E.E.
  • Mendrinou E.
  • Chalikiopoulou K.
  • Kolliopoulou A.
  • Mitropoulos K.
  • Stratopoulos A.
  • Liopetas I.
  • Tsikrika A.
  • Barba E.
  • Emmanouil G.
  • Stamopoulou T.
  • Stathoulias A.
  • Giannopoulos P.
  • Kanellakis F.
... View more Collapse

LANCET - 4/2/2023

10.1016/s0140-6736(22)01841-4

Cite count: 211 (Web of Science) 146 (Scopus)
  • JCR Impact Factor: 98.4 (2023)
  • CiteScore: 133.2 (2022)
  • JCR 5-year Impact Factor: 106.9
  • JCR Categories: MEDICINE, GENERAL & INTERNAL
Open Access

Azathioprine dose tailoring based on pharmacogenetic information: Insights of clinical implementation

  • Díaz-Villamarín X.
  • Fernández-Varón E.
  • Rojas Romero M.C.
  • Callejas-Rubio J.L.
  • Cabeza-Barrera J.
  • Rodríguez-Nogales A.
  • Gálvez J.
  • Morón R.
... View more Collapse

BIOMEDICINE & PHARMACOTHERAPY - 1/12/2023

10.1016/j.biopha.2023.115706

Cite count: 3 (Web of Science)
  • JCR Impact Factor: 6.9 (2023)
  • CiteScore: 12.6 (2022)
  • JCR 5-year Impact Factor: 6.8
  • JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL
Open Access

Pharmacogenetics of siponimod: A systematic review

  • Díaz-Villamarín X.
  • Piñar-Morales R.
  • Barrero-Hernández F.J.
  • Antúnez-Rodríguez A.
  • Cabeza-Barrera J.
  • Morón-Romero R.

BIOMEDICINE & PHARMACOTHERAPY - 1/9/2022

10.1016/j.biopha.2022.113536

Cite count: 9 (Web of Science) 8 (Scopus)
  • CiteScore: 12.6 (2022)
  • SJR: 1.366 (2022
  • SNIP: 1.576 (2022
Open Access

Genetic Polymorphisms in VEGFR Coding Genes (<i>FLT1</i>/<i>KDR</i>) on Ranibizumab Response in High Myopia and Choroidal Neovascularization Patients

  • Blánquez-Martínez D.
  • Díaz-Villamarín X.
  • García-Rodríguez S.
  • Antúnez-Rodríguez A.
  • Pozo-Agundo A.
  • Martínez-González L.J.
  • Muñoz-ávila J.I.
  • Dávila-Fajardo C.L.
... View more Collapse

PHARMACEUTICS - 26/8/2022

10.3390/pharmaceutics14081555

Cite count: 4 (Web of Science) 2 (Scopus)
Open Access

Pharmacogenomics decision support in the U-PGx project: Results and advice from clinical implementation across seven European countries

  • Blagec K.
  • Swen J.J.
  • Koopmann R.
  • Cheung K.C.
  • Crommentuijn-Van Rhenen M.
  • Holsappel I.
  • Konta L.
  • Ott S.
  • Steinberger D.
  • Xu H.
  • Cecchin E.
  • Dolžan V.
  • Dávila-Fajardo C.L.
  • Patrinos G.P.
  • Sunder-Plassmann G.
  • Turner R.M.
  • Pirmohamed M.
  • Guchelaar H.J.
  • Samwald M.
  • Antolinos-Perez M.J.
  • Blagus T.
  • Cambon-Thomsen A.
  • Deneer V.H.
  • Dupui M.
  • Franssen P.
  • Grandia L.
  • Hanson A.
  • Ingelman-Sundberg M.
  • Jama W.
  • Jonsson S.
  • Just K.
  • Karlsson M.O.
  • Katsila T.
  • Klen J.
  • Kriek M.
  • Lauschke V.M.
  • Díaz-Villamarín X.
  • Manson L.E.N.
  • Mitropoulou C.
  • Mlinsek G.
  • Moreno-Aguilar R.
  • Nijenhuis M.
  • Nordling
  • Poplas Susic A.
  • Rial-Sebbag E.
  • Rollinson V.
  • Sanchez-Ramos J.G.
  • Schaeffeler E.
  • Schmidt A.
  • Schwab M.
  • Sengoelge G.
  • Steffens M.
  • Stingl J.
  • Toffoli G.
  • Moreno Escobar E.
  • Tremmel R.
  • Tsermpini E.E.
  • van der Lee M.
  • Wojtyniak J.G.
  • van der Wouden C.H.
... View more Collapse

PLoS ONE - 1/6/2022

10.1371/journal.pone.0268534

Cite count: 16 (Scopus)
Open Access

Genetic Polymorphisms Affecting Ranibizumab Response in High Myopia Patients

  • Blánquez-Martínez D.
  • Díaz-Villamarín X.
  • Antúnez-Rodríguez A.
  • Pozo-Agundo A.
  • Muñoz-ávila J.I.
  • Martínez-González L.J.
  • Dávila-Fajardo C.L.
... View more Collapse

PHARMACEUTICS - 1/11/2021

10.3390/pharmaceutics13111973

Cite count: 4 (Web of Science) 4 (Scopus)
Open Access

Pharmacogenetic polymorphisms affecting bisoprolol response

  • Castaño-Amores C.
  • Díaz-Villamarín X.
  • Pérez-Gutiérrez A.M.
  • Antúnez-Rodríguez A.
  • Pozo-Agundo A.
  • Moreno-Escobar E.
  • Sánchez-Ramos J.G.
  • Martínez-González L.J.
  • Dávila-Fajardo C.L.
... View more Collapse

BIOMEDICINE & PHARMACOTHERAPY - 1/10/2021

10.1016/j.biopha.2021.112069

Cite count: 7 (Web of Science) 6 (Scopus)
  • CiteScore: 12.6 (2022)
  • SJR: 1.194 (2021
  • SNIP: 1.502 (2021

This author has no books, chapters or theses.

This author has no conferences.

This author has no patents.

Novel Genetic Variants Explaining Severe Adverse Drug Events after Clinical Implementation of DPYD Genotype-Guided Therapy with Fluoropyrimidines

10.20944/preprints202406.2074.v1

  • ORCID

Impact of the Implementation of a Selective Digestive Decontamination Protocol on Antibiotic Consumption in an Intensive Care Unit: A Quasi-Experimental Study

10.20944/preprints202407.2375.v1

  • ORCID

Scopus: 8

Web of Science: 9

Scopus: 8

Web of Science: 7

  • This author has no currently assigned projects.
Last data update: 11/30/24 8:29 AM
Next scheduled update: 12/7/24 3:00 AM